Related Experiment Video
Updated: May 13, 2026
09:41
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
Cardiomyopathy in neurological disorders.
Josef Finsterer1, Claudia Stöllberger, Karim Wahbi
1Krankenanstalt Rudolfstiftung, Vienna, Austria.
Summary
Cardiomyopathies, particularly secondary types linked to neuromuscular disorders, can cause neurological issues like stroke. Early cardiac and neurological evaluations are crucial for managing these interconnected conditions.
Area of Science:
- Cardiology
- Neurology
- Genetics
Background:
- Cardiomyopathies are heart muscle diseases with various classifications, including primary and secondary forms.
- Secondary cardiomyopathies involve myocardial issues within neuromuscular disorders or as a primary manifestation.
- Common types include hypertrophic, dilated, restrictive, and arrhythmogenic right ventricular cardiomyopathies.
Purpose of the Study:
- To review secondary cardiomyopathies and those predominantly manifesting from myopathies.
- To explore the relationship between cardiomyopathies and neurological disorders.
- To highlight management strategies for these interconnected conditions.
Main Methods:
- Literature review focusing on secondary cardiomyopathies and myopathy-related cardiomyopathies.
- Analysis of the interplay between cardiac and neurological manifestations.
- Synthesis of current management guidelines for associated neurological diseases and cardiomyopathies.
Main Results:
- Cardiomyopathies frequently lead to neurological diseases, primarily ischemic stroke and transient ischemic attacks.
- Neuromuscular disorders are commonly associated with cardiomyopathies, including muscular dystrophies and metabolic myopathies.
- Management of neurological complications and secondary cardiomyopathies follows standard protocols, with specific considerations for neuromuscular patients.
Conclusions:
- Patients with neuromuscular disorders need prompt cardiologic assessment and monitoring.
- Cardiomyopathy patients require neurological investigation and avoidance of myotoxic medications.
- Further research is needed to identify cardiomyopathy patients who benefit most from primary stroke prevention.
Related Concept Videos
01:25Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
01:28Disorders of the Nervous Tissue
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...